ENDPQ — Endo International Cashflow Statement
0.000.00%
Last trade - 00:00- $0.14m
- $7.37bn
- $2.01bn
- 26
- 92
- 15
- 41
Annual cashflow statement for Endo International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -423 | 184 | -613 | -2,923 | -2,450 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 431 | 206 | 485 | 2,304 | 909 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -518 | -348 | 85.3 | 504 | 1,665 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 98.1 | 397 | 411 | 269 | 435 |
| Capital Expenditures | -63.9 | -72 | -82.1 | -99.7 | -94.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 3.66 | -553 | 22.6 | -33.4 | 44.5 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -60.2 | -625 | -59.5 | -133 | -49.8 |
| Financing Cash Flow Items | -33.4 | -11.9 | -27.4 | -317 | -598 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 205 | -109 | -105 | -514 | -605 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 244 | -335 | 246 | -382 | -219 |